Rank 17 • AI & Clinical Intelligence
Lunit
Develops AI-powered software for cancer diagnostics and therapeutics, analyzing mammography, chest X-rays, and tissue pathology slides.
Visit website- Signal Score
- 91.9
- Total raised
- $140M
- Stage
- Public
- Founded
- 2013
- Headquarters
- Seoul, South Korea
- Region
- Asia-Pacific
Their signal
Lunit's global footprint and deep clinical validation make it a premier medical AI provider, expanding rapidly into global national screening programs.
Signal Score 91.9editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.